Sophia Mareike Geisler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sophia Mareike Geisler has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Annette Moter
Charité – Universitätsmedizin Berlin, Institute of Microbiology, Infectious Diseases and Immunology, Berlin, Germany
3 shared publicationsFelix Hehnen
Biofluid Mechanics Laboratory, Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany
3 shared publicationsIsabell Schulz
Biofluid Mechanics Laboratory, Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany
3 shared publicationsKarolin Senftleben
Section of Clinical Infectious Diseases, University Hospital Halle (Saale), Halle (Saale), Germany
3 shared publicationsSebastian Schimek
Institute of Fluid Dynamics and Technical Acoustics, Hermann-Föttinger-Institute, Chair of Fluid Dynamics, Technical University of Berlin, Berlin, Germany
3 shared publications- Stefan Moritz
Section of Clinical Infectious Diseases, University Hospital Halle, Halle, Germany
3 shared publications
Latest Publications
- Open Access
- 31 December 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e77792
Prescribing Experiences, Potentials, and Challenges of Digital Health Applications in the Field of Hormones and Metabolism: Cross-Sectional Survey Study of Health Care Providers in Germany
Background: In 2020, the global prevalence of overweight and obesity was approximately 42%. One of the most common associated conditions is type 2 diabetes mellitus, which had a global prevalence of around 10.5% in 2021. Digital health applications (DiHA), which can be prescribed as certified medical devices in Germany, have been shown to effectively support disease management in patients with overweight and diabetes mellitus. However, little is known about DiHA-prescribing behavior of health care providers (HCPs) specializing in hormones and metabolism or about potential barriers to prescribing these applications. Objective: This study aimed to assess HCPs’ experience with and willingness to prescribe DiHA in the field of hormones and metabolism. In addition, it sought to examine the patient-relevant health care effects that HCPs perceive as potentially achievable or have already observed with DiHA use, as well as the barriers they perceive to prescribing these applications. Methods: An online questionnaire was developed based on preliminary studies and a literature review consisting of 86 items covering 6 key areas: experience and willingness to prescribe, health care effects, barriers, scientific evidence, digital affinity, and sociodemographics. The anonymous survey was distributed via the German Diabetes Association to 6035 HCPs in Germany between August 2 and October 9, 2024. Descriptive analyses, as well as correlation and regression analyses, were conducted. Results: A total of 350 HCPs participated in the survey (response rate=5.8%). Although the low response rate may limit generalizability, the findings provide insights into prescribing behavior within this specialty. More than half (187/350, 53.4%) had never prescribed any of the 54 DiHA available at the time of the survey, with 47.6% (89/187) citing a lack of experience as the primary reason. Among those who had prescribed a DiHA (163/350, 46.6%), the majority (139/163, 85.3%) had prescribed 1 of the 8 DiHA available for obesity or diabetes mellitus. Looking ahead, 42.9% (149/348) of all surveyed HCPs stated that they were either very unlikely (83/348, 23.9%) or somewhat unlikely (66/348, 19%) to prescribe these DiHA in the next 12 months. The greatest perceived benefits of DiHA were improvements in self-management, health literacy, and adherence. The main barriers to prescribing DiHA in the field of hormones and metabolism included inadequate reimbursement for ancillary medical services, poor compatibility with existing practice software, and a lack of digital affinity or motivation among patients. Conclusions: DiHA have not yet been fully integrated into standard health care. To improve prescribing, we recommend integrating DiHA into medical guidelines, ensuring proper reimbursement, and involving HCPs in the pricing and health-economic evaluation of DiHA. The recommendations outlined should be considered to maximize DiHA’s potential and improve HCPs' acceptance, providing valuable insights for health policy to enhance the integration, reimbursement, and use of DiHA.
- 31 December 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e77792
Open AccessPrescribing Experiences, Potentials, and Challenges of Digital Health Applications in the Field of Hormones and Metabolism: Cross-Sectional Survey Study of Health Care Providers in Germany
Background: In 2020, the global prevalence of overweight and obesity was approximately 42%. One of the most common associated conditions is type 2 diabetes mellitus, which had a global prevalence of around 10.5% in 2021. Digital health applications (DiHA), which can be prescribed as certified medical devices in Germany, have been shown to effectively support disease management in patients with overweight and diabetes mellitus. However, little is known about DiHA-prescribing behavior of health care providers (HCPs) specializing in hormones and metabolism or about potential barriers to prescribing these applications. Objective: This study aimed to assess HCPs’ experience with and willingness to prescribe DiHA in the field of hormones and metabolism. In addition, it sought to examine the patient-relevant health care effects that HCPs perceive as potentially achievable or have already observed with DiHA use, as well as the barriers they perceive to prescribing these applications. Methods: An online questionnaire was developed based on preliminary studies and a literature review consisting of 86 items covering 6 key areas: experience and willingness to prescribe, health care effects, barriers, scientific evidence, digital affinity, and sociodemographics. The anonymous survey was distributed via the German Diabetes Association to 6035 HCPs in Germany between August 2 and October 9, 2024. Descriptive analyses, as well as correlation and regression analyses, were conducted. Results: A total of 350 HCPs participated in the survey (response rate=5.8%). Although the low response rate may limit generalizability, the findings provide insights into prescribing behavior within this specialty. More than half (187/350, 53.4%) had never prescribed any of the 54 DiHA available at the time of the survey, with 47.6% (89/187) citing a lack of experience as the primary reason. Among those who had prescribed a DiHA (163/350, 46.6%), the majority (139/163, 85.3%) had prescribed 1 of the 8 DiHA available for obesity or diabetes mellitus. Looking ahead, 42.9% (149/348) of all surveyed HCPs stated that they were either very unlikely (83/348, 23.9%) or somewhat unlikely (66/348, 19%) to prescribe these DiHA in the next 12 months. The greatest perceived benefits of DiHA were improvements in self-management, health literacy, and adherence. The main barriers to prescribing DiHA in the field of hormones and metabolism included inadequate reimbursement for ancillary medical services, poor compatibility with existing practice software, and a lack of digital affinity or motivation among patients. Conclusions: DiHA have not yet been fully integrated into standard health care. To improve prescribing, we recommend integrating DiHA into medical guidelines, ensuring proper reimbursement, and involving HCPs in the pricing and health-economic evaluation of DiHA. The recommendations outlined should be considered to maximize DiHA’s potential and improve HCPs' acceptance, providing valuable insights for health policy to enhance the integration, reimbursement, and use of DiHA.
- Open Access
- 24 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Prescribing Experiences, Potentials, and Challenges of Digital Health Applications in the Field of Hormones and Metabolism: Cross-Sectional Survey Study of Health Care Providers in Germany (Preprint)
BACKGROUND In 2020, the global prevalence of overweight and obesity was approximately 42%. One of the most common associated conditions is type 2 diabetes mellitus, which had a global prevalence of around 10.5% in 2021. Digital health applications (DiHA), which can be prescribed as certified medical devices in Germany, have been shown to effectively support disease management in patients with overweight and diabetes mellitus. However, little is known about DiHA-prescribing behavior of health care providers (HCPs) specializing in hormones and metabolism or about potential barriers to prescribing these applications. OBJECTIVE This study aimed to assess HCPs’ experience with and willingness to prescribe DiHA in the field of hormones and metabolism. In addition, it sought to examine the patient-relevant health care effects that HCPs perceive as potentially achievable or have already observed with DiHA use, as well as the barriers they perceive to prescribing these applications. METHODS An online questionnaire was developed based on preliminary studies and a literature review consisting of 86 items covering 6 key areas: experience and willingness to prescribe, health care effects, barriers, scientific evidence, digital affinity, and sociodemographics. The anonymous survey was distributed via the German Diabetes Association to 6035 HCPs in Germany between August 2 and October 9, 2024. Descriptive analyses, as well as correlation and regression analyses, were conducted. RESULTS A total of 350 HCPs participated in the survey (response rate=5.8%). Although the low response rate may limit generalizability, the findings provide insights into prescribing behavior within this specialty. More than half (187/350, 53.4%) had never prescribed any of the 54 DiHA available at the time of the survey, with 47.6% (89/187) citing a lack of experience as the primary reason. Among those who had prescribed a DiHA (163/350, 46.6%), the majority (139/163, 85.3%) had prescribed 1 of the 8 DiHA available for obesity or diabetes mellitus. Looking ahead, 42.9% (149/348) of all surveyed HCPs stated that they were either very unlikely (83/348, 23.9%) or somewhat unlikely (66/348, 19%) to prescribe these DiHA in the next 12 months. The greatest perceived benefits of DiHA were improvements in self-management, health literacy, and adherence. The main barriers to prescribing DiHA in the field of hormones and metabolism included inadequate reimbursement for ancillary medical services, poor compatibility with existing practice software, and a lack of digital affinity or motivation among patients. CONCLUSIONS DiHA have not yet been fully integrated into standard health care. To improve prescribing, we recommend integrating DiHA into medical guidelines, ensuring proper reimbursement, and involving HCPs in the pricing and health-economic evaluation of DiHA. The recommendations outlined should be considered to maximize DiHA’s potential and improve HCPs' acceptance, providing valuable insights for health policy to enhance the integration, reimbursement, and use of DiHA.
- 24 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPrescribing Experiences, Potentials, and Challenges of Digital Health Applications in the Field of Hormones and Metabolism: Cross-Sectional Survey Study of Health Care Providers in Germany (Preprint)
BACKGROUND In 2020, the global prevalence of overweight and obesity was approximately 42%. One of the most common associated conditions is type 2 diabetes mellitus, which had a global prevalence of around 10.5% in 2021. Digital health applications (DiHA), which can be prescribed as certified medical devices in Germany, have been shown to effectively support disease management in patients with overweight and diabetes mellitus. However, little is known about DiHA-prescribing behavior of health care providers (HCPs) specializing in hormones and metabolism or about potential barriers to prescribing these applications. OBJECTIVE This study aimed to assess HCPs’ experience with and willingness to prescribe DiHA in the field of hormones and metabolism. In addition, it sought to examine the patient-relevant health care effects that HCPs perceive as potentially achievable or have already observed with DiHA use, as well as the barriers they perceive to prescribing these applications. METHODS An online questionnaire was developed based on preliminary studies and a literature review consisting of 86 items covering 6 key areas: experience and willingness to prescribe, health care effects, barriers, scientific evidence, digital affinity, and sociodemographics. The anonymous survey was distributed via the German Diabetes Association to 6035 HCPs in Germany between August 2 and October 9, 2024. Descriptive analyses, as well as correlation and regression analyses, were conducted. RESULTS A total of 350 HCPs participated in the survey (response rate=5.8%). Although the low response rate may limit generalizability, the findings provide insights into prescribing behavior within this specialty. More than half (187/350, 53.4%) had never prescribed any of the 54 DiHA available at the time of the survey, with 47.6% (89/187) citing a lack of experience as the primary reason. Among those who had prescribed a DiHA (163/350, 46.6%), the majority (139/163, 85.3%) had prescribed 1 of the 8 DiHA available for obesity or diabetes mellitus. Looking ahead, 42.9% (149/348) of all surveyed HCPs stated that they were either very unlikely (83/348, 23.9%) or somewhat unlikely (66/348, 19%) to prescribe these DiHA in the next 12 months. The greatest perceived benefits of DiHA were improvements in self-management, health literacy, and adherence. The main barriers to prescribing DiHA in the field of hormones and metabolism included inadequate reimbursement for ancillary medical services, poor compatibility with existing practice software, and a lack of digital affinity or motivation among patients. CONCLUSIONS DiHA have not yet been fully integrated into standard health care. To improve prescribing, we recommend integrating DiHA into medical guidelines, ensuring proper reimbursement, and involving HCPs in the pricing and health-economic evaluation of DiHA. The recommendations outlined should be considered to maximize DiHA’s potential and improve HCPs' acceptance, providing valuable insights for health policy to enhance the integration, reimbursement, and use of DiHA.
- Open Access
- 9 November 2024
- Published by Springer Nature in Communications Engineering
- Vol. 3 (1) , 1-15
Comparing strategies for the mitigation of SARS-CoV-2 airborne infection risk in tiered auditorium venues
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the magnitude of effect of various mitigation measures and to develop recommendations. Here we show that, in general, positions in the near field of an emission source were at high risk, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy, airflow rate, residence time, virus variants, activity level and face masks affected the individual and global infection risk in all venues. The global infection risk was lowest for the displacement ventilation case, making it the most effective ventilation strategy for keeping airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
- 9 November 2024
- Published by Springer Nature in Communications Engineering
- Vol. 3 (1) , 1-15
Open AccessComparing strategies for the mitigation of SARS-CoV-2 airborne infection risk in tiered auditorium venues
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the magnitude of effect of various mitigation measures and to develop recommendations. Here we show that, in general, positions in the near field of an emission source were at high risk, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy, airflow rate, residence time, virus variants, activity level and face masks affected the individual and global infection risk in all venues. The global infection risk was lowest for the displacement ventilation case, making it the most effective ventilation strategy for keeping airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
- 22 October 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (10) , e70003
Effects of Mobile Application‐Based Cognitive Behavioral Therapy on Psychological Outcomes in Women Treated for Breast Cancer: A Randomized Controlled Pilot Trial in Germany
Objective: Breast cancer has a strong impact on the mental state of those affected. Cognitive behavioral therapy (CBT) is one effective approach to reduce disease burden. This randomized controlled pilot trial aimed to assess the effect of the digital CBT‐based application Living Well on psychological outcomes in a German female breast cancer population.Methods: Female breast cancer patients (n = 70) with ongoing or finished oncological treatment that is who were receiving or had received any type of oncological treatment were included in the study and randomized to an intervention group (IG, n = 32) receiving Living Well in addition to care as usual, and a control group (CG, n = 38) receiving care as usual only. Participants completed standardized questionnaires at baseline and after 2, 4, 8, and 12 weeks to assess anxiety and depression (HADS) as primary outcomes, distress (DT), health‐related quality of life (HRQoL, AQoL‐8D), and illness perception (B‐IPQ) as secondary outcomes.Results: After 12 weeks, significant (p < 0.05) higher improvements in the IG could be observed in anxiety levels, HRQoL, and illness perception, when compared to the CG. Age and time since diagnosis were found to be relevant covariates for anxiety levels. In distress levels, the IG showed a clinically relevant and nearly significant reduction compared to the CG (p = 0.057). No effects could be observed in depression levels.Conclusions: The results demonstrate the potential of Living Well to improve psychological outcomes of female breast cancer patients and encourage further studies evaluating the effectiveness of the digital application.Trial Registration: The trial has been registered in the German Clinical Trials Register (DRKS00029918)
- 22 October 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (10) , e70003
Effects of Mobile Application‐Based Cognitive Behavioral Therapy on Psychological Outcomes in Women Treated for Breast Cancer: A Randomized Controlled Pilot Trial in Germany
Objective: Breast cancer has a strong impact on the mental state of those affected. Cognitive behavioral therapy (CBT) is one effective approach to reduce disease burden. This randomized controlled pilot trial aimed to assess the effect of the digital CBT‐based application Living Well on psychological outcomes in a German female breast cancer population.Methods: Female breast cancer patients (n = 70) with ongoing or finished oncological treatment that is who were receiving or had received any type of oncological treatment were included in the study and randomized to an intervention group (IG, n = 32) receiving Living Well in addition to care as usual, and a control group (CG, n = 38) receiving care as usual only. Participants completed standardized questionnaires at baseline and after 2, 4, 8, and 12 weeks to assess anxiety and depression (HADS) as primary outcomes, distress (DT), health‐related quality of life (HRQoL, AQoL‐8D), and illness perception (B‐IPQ) as secondary outcomes.Results: After 12 weeks, significant (p < 0.05) higher improvements in the IG could be observed in anxiety levels, HRQoL, and illness perception, when compared to the CG. Age and time since diagnosis were found to be relevant covariates for anxiety levels. In distress levels, the IG showed a clinically relevant and nearly significant reduction compared to the CG (p = 0.057). No effects could be observed in depression levels.Conclusions: The results demonstrate the potential of Living Well to improve psychological outcomes of female breast cancer patients and encourage further studies evaluating the effectiveness of the digital application.Trial Registration: The trial has been registered in the German Clinical Trials Register (DRKS00029918)
- Open Access
- 27 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (13) , 5601
Experimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention on the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the naturally ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in variously sized and shaped indoor environments, with or without an audience.
- 27 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (13) , 5601
Open AccessExperimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention on the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the naturally ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in variously sized and shaped indoor environments, with or without an audience.
- Open Access
- 9 October 2023
- Published by Springer Nature in Research Square
SARS-CoV-2 airborne infection risk in venues with different ventilation strategies – a comparison between experimental, numerical and analytical approaches
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the effect size of different mitigation measures and to develop recommendations. In general, positions in the near field of an emission source were at high risk in all ventilation systems studied, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy rate, airflow rate, residence time, SARS-CoV-2 virus variants, a high activity level and face masks affected the individual and global infection risk in all venues. The global infection risk was lowest for the displacement ventilation case and highest for the naturally ventilated venue. Therefore, in our study, a properly designed displacement ventilation system is the most effective ventilation strategy to keep airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
- 9 October 2023
- Published by Springer Nature in Research Square
Open AccessSARS-CoV-2 airborne infection risk in venues with different ventilation strategies – a comparison between experimental, numerical and analytical approaches
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the effect size of different mitigation measures and to develop recommendations. In general, positions in the near field of an emission source were at high risk in all ventilation systems studied, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy rate, airflow rate, residence time, SARS-CoV-2 virus variants, a high activity level and face masks affected the individual and global infection risk in all venues. The global infection risk was lowest for the displacement ventilation case and highest for the naturally ventilated venue. Therefore, in our study, a properly designed displacement ventilation system is the most effective ventilation strategy to keep airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
- Open Access
- 21 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11776
Ectopic Lipid Accumulation Correlates with Cellular Stress in Rabbit Blastocysts from Diabetic Mothers
Maternal diabetes mellitus in early pregnancy leads to hyperlipidemia in reproductive tract organs and an altered embryonic environment. To investigate the consequences on embryonic metabolism, the effect of high environmental-lipid levels was studied in rabbit blastocysts cultured with a lipid mixture in vitro and in blastocysts from diabetic, hyperlipidemic rabbits in vivo. The gene and protein expression of marker molecules involved in lipid metabolism and stress response were analyzed. In diabetic rabbits, the expression of embryoblast genes encoding carnitine palmityl transferase 1 and peroxisome proliferator-activated receptors α and γ increased, whereas trophoblast genes encoding for proteins associated with fatty acid synthesis and β-oxidation decreased. Markers for endoplasmic (activating transcription factor 4) and oxidative stress (nuclear factor erythroid 2-related factor 2) were increased in embryoblasts, while markers for cellular redox status (superoxide dismutase 2) and stress (heat shock protein 70) were increased in trophoblasts from diabetic rabbits. The observed regulation pattern in vivo was consistent with an adaptation response to the hyperlipidemic environment, suggesting that maternal lipids have an impact on the intracellular metabolism of the preimplantation embryo in diabetic pregnancy and that embryoblasts are particularly vulnerable to metabolic stress.
- 21 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11776
Open AccessEctopic Lipid Accumulation Correlates with Cellular Stress in Rabbit Blastocysts from Diabetic Mothers
Maternal diabetes mellitus in early pregnancy leads to hyperlipidemia in reproductive tract organs and an altered embryonic environment. To investigate the consequences on embryonic metabolism, the effect of high environmental-lipid levels was studied in rabbit blastocysts cultured with a lipid mixture in vitro and in blastocysts from diabetic, hyperlipidemic rabbits in vivo. The gene and protein expression of marker molecules involved in lipid metabolism and stress response were analyzed. In diabetic rabbits, the expression of embryoblast genes encoding carnitine palmityl transferase 1 and peroxisome proliferator-activated receptors α and γ increased, whereas trophoblast genes encoding for proteins associated with fatty acid synthesis and β-oxidation decreased. Markers for endoplasmic (activating transcription factor 4) and oxidative stress (nuclear factor erythroid 2-related factor 2) were increased in embryoblasts, while markers for cellular redox status (superoxide dismutase 2) and stress (heat shock protein 70) were increased in trophoblasts from diabetic rabbits. The observed regulation pattern in vivo was consistent with an adaptation response to the hyperlipidemic environment, suggesting that maternal lipids have an impact on the intracellular metabolism of the preimplantation embryo in diabetic pregnancy and that embryoblasts are particularly vulnerable to metabolic stress.
- Open Access
Airborne infection risk in venues with different ventilation strategies – a comparison between experimental, numerical and analytical approaches
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the effect size of different mitigation measures and to develop recommendations. In general, positions in the near field of an emission source were at high risk in all ventilation systems studied, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy rate, airflow rate, residence time, SARS-CoV-2 virus variants, a high activity level and face masks affected the individual and total infection risk in all venues. The total infection risk was lowest for the displacement ventilation case and highest for the naturally ventilated venue. Therefore, in our study, a properly designed displacement ventilation system is the most effective ventilation strategy to keep airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
Open AccessAirborne infection risk in venues with different ventilation strategies – a comparison between experimental, numerical and analytical approaches
The COVID-19 pandemic demonstrated that reliable risk assessment of venues is still challenging and resulted in the indiscriminate closure of many venues worldwide. Therefore, this study used an experimental, numerical and analytical approach to investigate the airborne transmission risk potential of differently ventilated, sized and shaped venues. The data were used to assess the effect size of different mitigation measures and to develop recommendations. In general, positions in the near field of an emission source were at high risk in all ventilation systems studied, while the risk of infection from positions in the far field varied depending on the ventilation strategy. Occupancy rate, airflow rate, residence time, SARS-CoV-2 virus variants, a high activity level and face masks affected the individual and total infection risk in all venues. The total infection risk was lowest for the displacement ventilation case and highest for the naturally ventilated venue. Therefore, in our study, a properly designed displacement ventilation system is the most effective ventilation strategy to keep airborne transmission and the number of secondary cases low, compared to mixing or natural ventilation.
- 21 June 2022
- Published by Taylor & Francis in Journal of Sport & Tourism
- Vol. 26 (3) , 285-296
Evaluation of hygiene measures at a series of mass gathering events during the COVID-19 pandemic
After several months of an almost total ban on mass gathering events (MGE) due to the coronavirus disease 2019 (COVID-19), the cultural, creative and event industry (CCEI) is trying to return to commercially viable event occupancy rates while keeping SARS-CoV-2 transmission at a low level. To support this, we assessed the suitability and feasibility of a hygiene concept during a series of regular handball matches in May and June 2021 with increasing spectator numbers by on-site observation. In addition, questionnaires were distributed to the audience at the first and last event to obtain information about the spectators’ compliance with hygiene measures, vaccination status, feeling of safety and willingness of re-attendance. Spectator's compliance with the hygiene measures was high except for the social distancing regulation. Survey respondents reported a high sense of safety and willingness to re-attend despite the pandemic situation and regardless of vaccination status or antigen test result. Hygiene stewards became an increasingly effective support over the course of the event series. In conclusion, the event series with increasing spectator numbers consolidated and optimised hygiene concept-related processes and clearly demonstrated a high level of spectator compliance with the hygiene measures, supporting full capacity events in pandemic situations in future. Abbreviations: CCEI: cultural, creative and event industry; COVID-19: coronavirus disease 2019; MGE: mass-gathering event; SARS-CoV-2: severe acute respiratory syndrome coronavirus type 2; TVR certificates: antigen test, proof of vaccination or recovery certificates
- 21 June 2022
- Published by Taylor & Francis in Journal of Sport & Tourism
- Vol. 26 (3) , 285-296
Evaluation of hygiene measures at a series of mass gathering events during the COVID-19 pandemic
After several months of an almost total ban on mass gathering events (MGE) due to the coronavirus disease 2019 (COVID-19), the cultural, creative and event industry (CCEI) is trying to return to commercially viable event occupancy rates while keeping SARS-CoV-2 transmission at a low level. To support this, we assessed the suitability and feasibility of a hygiene concept during a series of regular handball matches in May and June 2021 with increasing spectator numbers by on-site observation. In addition, questionnaires were distributed to the audience at the first and last event to obtain information about the spectators’ compliance with hygiene measures, vaccination status, feeling of safety and willingness of re-attendance. Spectator's compliance with the hygiene measures was high except for the social distancing regulation. Survey respondents reported a high sense of safety and willingness to re-attend despite the pandemic situation and regardless of vaccination status or antigen test result. Hygiene stewards became an increasingly effective support over the course of the event series. In conclusion, the event series with increasing spectator numbers consolidated and optimised hygiene concept-related processes and clearly demonstrated a high level of spectator compliance with the hygiene measures, supporting full capacity events in pandemic situations in future. Abbreviations: CCEI: cultural, creative and event industry; COVID-19: coronavirus disease 2019; MGE: mass-gathering event; SARS-CoV-2: severe acute respiratory syndrome coronavirus type 2; TVR certificates: antigen test, proof of vaccination or recovery certificates
- 1 January 2019
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 480, 167-179
Trophoblastic microRNAs are downregulated in a diabetic pregnancy through an inhibition of Drosha
- 1 January 2019
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 480, 167-179
Trophoblastic microRNAs are downregulated in a diabetic pregnancy through an inhibition of Drosha